Efficacy and long-term outcomes of dopamine agonist treatment in prolactinomas

Key Points

• Dopamine agonist treatment significantly improves hormonal response in patients with prolactinomas, promoting effective management of the condition.
• In a cohort of patients undergoing treatment, long-term outcomes show sustained hormonal control and reduced tumor size after therapy.
• Analysis across multiple settings highlights the efficacy of dopamine agonists in managing prolactinomas effectively over extended periods.
• These findings may enable more tailored treatment plans and underlines the importance of monitoring long-term outcomes in prolactinoma management.